Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a haemopoietic growth factor that acts though a ternary receptor signalling complex containing specific (GMR) and common (c) receptor subunits. Human GM-CSF is encoded by the gene csf2, while the genes for GMR and c are csf2ra and csf2rb, respectively. Crystals of the ternary ectodomain complex comprising GM-CSF and the soluble extracellular regions of both the GMR subunit and either c or its glutamine-substitution mutant N346Q were obtained using the hanging-drop vapour-diffusion method. The best diffracting crystals of the ternary complex were obtained using the N346Q mutation of the c subunit. These crystals grew using polyethylene glycol 3350 with a high concentration of proline, belonged to space group P6 3 22 and diffracted to 3.3 Å resolution.
Introduction
Granulocyte-macrophage colony-stimulating factor (GM-CSF) belongs to a family of haematopoietic cytokines that includes interleukin-3 (IL-3) and IL-5. They are produced by activated T cells to stimulate the proliferation, differentiation, survival and functional activation of haemopoietic cells (Metcalf, 1993) . GM-CSF is also produced by macrophages, endothelial cells and fibroblasts to control dendritic cell and T-cell function. Conversely, these cytokines have all been implicated in multiple pathologies resulting from their excessive or aberrant expression or that of their receptors in conditions such as arthritis, asthma, chronic obstructive pulmonary disease, autoimmunity and leukaemia. In addition, recombinant human GM-CSF is used clinically to reduce the severity of chemotherapy-induced neutropenia and accelerate haematopoietic recovery after bonemarrow transplantation (Cebon & Lieschke, 1994; Armitage, 1998) .
GM-CSF, IL-3 and IL-5 exert their effects on target cells by binding to heterodimeric cell-surface receptors composed of a cytokine-specific subunit (Gearing et al., 1989; Kitamura et al., 1991; Tavernier et al., 1991; Murata et al., 1992; Takaki et al., 1993) and a c subunit (Hayashida et al., 1990) that is common to all three receptors. The subunit binds a cytokine with low affinity, forming a complex that then binds with high affinity to the c subunit. This process of receptor dimerization results in the activation of intracellular signal transduction pathways, although the mechanism remains poorly understood.
Both the GMR and c receptor subunits are type I transmembrane glycoproteins. The GMR subunit has an apparent molecular weight of 84 kDa with 11 potential N-linked glycosylation sites within the extracellular ligand-binding domain (Gearing et al., 1989) , while the c subunit has a molecular weight of 130 kDa and contains three N-linked glycosylation sites that are located in the extracellular region (Hayashida et al., 1990) . Structurally, both of these receptor subunits are characterized by the presence of cytokine-receptor homology modules, each consisting of two fibronectin type III domains. The N-terminal fibronectin type III domain contains four strictly conserved cysteine residues, while a highly conserved WSXWS motif is present near the C-terminus of the second domain.
The c subunit comprises two of these cytokine-receptor homology modules, while the GMR has a single module together with an N-terminally located 'knob' domain of unknown function.
The stoichiometry of the fully assembled GM-CSF receptor complex has been controversial. We have shown that a soluble form of the ternary GM-CSF receptor complex contained a single molecule of GM-CSF, a single molecule of GMR and two molecules of c (McClure et al., 2003) . However, a more recent analysis revealed that at high cytokine concentrations a 2:2:2 complex can form (unpublished results).
The crystals reported here will form the basis for determining the molecular structure of the ternary GM-CSF receptor complex and will clarify the nature of the interactions involved in cytokine binding, affinity conversion, receptor activation and signal transduction.
Experimental procedures and results

Protein expression, purification and complex formation
Soluble recombinant human GM-CSF was expressed in Escherichia coli and purified by anion-exchange chromatography and reversed-phase HPLC (Hercus et al., 1994) . The soluble extracellular regions of human GMR (sGMR; residues 1-320) or human c (sc; residues 1-438) were cloned into the pIBV5-His expression vector (Invitrogen, Australia) and transfected into Sf21 insect cells using Cellfectin (Invitrogen, Australia). Stable transfected Sf21 cell lines were selected for by incubation with blasticidin at 50 mg ml À1 (Invitrogen, Australia). Once cells lines had been established, blasticidin treatment was discontinued. Sf21 cells and transfected cell lines were maintained in serum-free ExCell 420 medium (JRH Biosciences, Australia) at 300 K. Large-scale expression generated up to 30 l of conditioned medium, which was concentrated to less than 1 l prior to affinity chromatography as previously described (McClure et al., 2003) .
Human c contains three N-linked glycosylation sites. Mutation of one site, Asn346, to Gln has been shown by others to improve the diffraction properties of crystallized sc (Carr et al., 2001) . Fulllength c-N346Q retains wild-type function when co-transfected with full-length GMR in GM-CSF receptor-binding assays using transiently transfected COS cells (results not shown). Site-directed mutagenesis using PCR was used to generate sc-N346Q, which was SDS-PAGE of the ternary GM-CSF complex containing GM-CSF, soluble GMR and the N346Q soluble c mutant. The concentrated ternary complex was separated by electrophoresis on a 10-20% polyacrylamide gradient gel under reducing conditions. GM-CSF migrated with an apparent molecular weight of 14 kDa, sGMR had a molecular weight of 42 kDa and sc-N346Q had a molecular weight of 52 kDa. Both receptor subunits migrated as broad bands owing to glycosylation. subsequently cloned into the pIBV5-His expression vector, expressed and purified as outlined for wild-type sc. Purified sc-N346Q showed a slight reduction in molecular weight compared with the wild-type sc but no difference in its ability to form a ternary complex with sGMR and GM-CSF (results not shown).
Ternary complexes consisting of GM-CSF, sGMR and either sc or the glutamine-substituted mutant sc-N346Q were isolated by gelfiltration chromatography using a Superdex 200 column (26 Â 600 mm; GE Healthcare, Australia) equilibrated with 150 mM NaCl, 50 mM sodium phosphate pH 7.0 at 277 K. The peak containing all three components as identified by SDS-PAGE was pooled, bufferexchanged into 10 mM HEPES pH 7.0 and concentrated to between 4 and 6 mg ml À1 (Amicon Ultra-10 centrifugal concentrator, Millipore, Australia; Fig. 1 ).
Protein crystallization
Crystallization trials were performed at both 277 and 293 K using the hanging-drop vapour-diffusion method by mixing 1-2 ml protein solution with an equal volume of reservoir solution and equilibrating against 1 ml reservoir solution. The initial crystallization conditions were established using the screens described by Jancarik & Kim (1991) and Cudney et al. (1994) .
Initial screening of the wild-type complex resulted in numerous small crystals appearing within 30 min at 293 K in conditions buffered between pH 6.0 and 8.0 using various molecular-weight polyethylene glycols (PEGs; 3350, 4000, 6000, 8000) as precipitants. Crystal size was optimized by a combination of streak-seeding, lower concentrations [7-12%(w/v)] of the high-molecular-weight PEGs, addition of 5%(v/v) 2,4-methylpentanediol (MPD) to the reservoir solution and incubation of the trays at 277 K. A number of different crystal forms were obtained (Figs. 2a and 2b) . These crystals were very sensitive to handling.
Screening of the ternary GM-CSF receptor complex comprising the sc-N346Q mutation around the conditions that produced wildtype crystals resulted in large crystals that grew within a week at 277 K (Fig. 2c) . These crystals were once again sensitive to handling. Further screening with PEGs as precipitants resulted in the identification of a morphologically distinct hexagonal form that grew slowly over six weeks at 277 K using PEG 550 monomethyl ether as the precipitant (Fig. 2d) . Optimization of this hexagonal crystal form resulted in large single hexagonal crystals that grew at 293 K using 100 mM HEPES pH 7.0, 6%(w/v) PEG 3350 and 200 mM proline as an additive. Crystals appeared after one week and grew to full size (800 Â 800 Â 400 mm) within two weeks (Figs. 2e and 2f ).
Data collection and preliminary X-ray analysis
Initial X-ray diffraction studies were performed on the wild-type ternary GM-CSF receptor complex crystals using an in-house MAR345 image-plate detector with Cu K X-rays generated by a Rigaku RU-200 rotating-anode X-ray generator. These crystals diffracted very weakly to 23 Å resolution following a 60 min exposure at 293 K. The crystals were extremely fragile and sensitive to cryoprotection. Eventually, conditions were determined under which the crystals could be frozen, involving stepwise addition of glycerol at 5%(v/v) intervals to a final concentration of 20-25%(v/v). The best wild-type crystals failed to diffract beyond 8 Å resolution using synchrotron radiation. Numerous methods were tried to optimize the quality of these crystals, including controlled dehydration, crystal annealing and growing the crystals in a magnetic field; however, none proved successful.
Crystals of the ternary complex containing the sc-N346Q mutation grown under similar conditions to the wild-type crystals also failed to diffract beyond 8 Å resolution. Hexagonal crystals grown at 277 K in 100 mM HEPES pH 7.5, 10%(v/v) PEG 550 monomethyl ether and 5%(v/v) MPD were flash-frozen after stepwise transfer into the final cryo-buffer. The glycerol cryoprotectant was added in steps of 5%(v/v) up to 20%(v/v) in stabilizing buffer containing 100 mM HEPES pH 7.5, 15%(v/v) PEG 550 monomethyl ether and 5%(v/v) MPD. As the crystals were relatively large (200-300 mm in each dimension), the soaking time for each 5% increment was 20 min to ensure that diffraction quality was preserved. A complete X-ray diffraction data set was measured at 100 K using an ADSC Quantum- oscillation image of the data collected from a crystal of the ternary GM-CSF receptor complex using the sc-N346Q construct, showing Bragg reflections extending beyond 3.6 Å resolution. This image was collected using an ADSC Quantum-210 CCD detector from a crystal frozen at 100 K on IMCA-CAT beamline 17-ID at the Advanced Photon Source, Chicago, USA.
